TITLE

Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure

AUTHOR(S)
Kumar, Ramesh; Shalimar; Sharma, Hanish; Goyal, Rohit; Kumar, Ajay; Khanal, Shankar; Prakash, Shyam; Gupta, S. Datta; Panda, Subrat Kumar; Acharya, Subrat Kumar
PUB. DATE
July 2012
SOURCE
Gut;Jul2012, Vol. 61 Issue 7, p1068
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: It is difficult to predict the outcome in patients with acute liver failure (ALF) using existing prognostic models. This study investigated whether early changes in the levels of dynamic variables can predict outcome better than models based on static baseline variables. Design: 380 patients with ALF (derivation cohort n=244, validation cohort n=136) participated in a prospective observational study. The derivation cohort was used to identify predictors of mortality. The ALF early dynamic (ALFED) model was constructed based on whether the levels of predictive variables remained persistently high or increased over 3 days above the discriminatory cut-off values identified in this study. The model had four variables: arterial ammonia, serum bilirubin, international normalised ratio and hepatic encephalopathy >grade II. The model was validated in a cohort of 136 patients with ALF. Results: The ALFED model demonstrated excellent discrimination with an area under the receiver operator characteristic curve of 0.91 in the derivation cohort and of 0.92 in the validation cohort. The model was well calibrated in both cohorts and showed a similar increase in mortality with increasing risk scores from 0 to 6. The performance of the ALFED model was superior to the King's College Hospital criteria and the Model for End stage Liver Disease score, even when their 3-day serial values were taken into consideration. An ALFED score of ≥4 had a high positive predictive value (85%) and negative predictive value (87%) in the validation cohort. Conclusion: The ALFED model accurately predicted outcome in patients with ALF, which may be useful in clinical decision-making. INSET: Significance of this study.
ACCESSION #
76169843

 

Related Articles

  • Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial. Jamal-Hanjani, M.; A'Hern, R.; Birkbak, N. J.; Gorman, P.; Grönroos, E.; Ngang, S.; Nicola, P.; Rahman, L.; Thanopoulou, E.; Kelly, G.; Ellis, P.; Barrett-Lee, P.; Johnston, S. R. D.; Bliss, J.; Roylance, R.; Swanton, C. // Annals of Oncology;Jul2015, Vol. 26 Issue 7, p1340 

    Background: Chromosomal instability (CIN) has been shown to be associated with drug resistance and poor clinical outcome in several cancer types. However, in oestrogen receptor (ER)-negative breast cancer we have previously demonstrated that extreme CIN is associated with improved clinical...

  • The Need for Perspective in Evidence-Based Medicine. Woolf, Steven H. // JAMA: Journal of the American Medical Association;12/22/99, Vol. 282 Issue 24, p2357 

    Considers how research advances are generating a growing body of clinical trial and other data on the effects of tests and treatments on outcomes, but there is no information resource within the health care system that systematically puts that information in perspective. Proposal of a...

  • In the January BJA . . .  // BJA: The British Journal of Anaesthesia;Jan2016, Vol. 116 Issue 1, preceding p1 

    No abstract available.

  • Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials. Lifson, Alan R.; Belloso, Waldo H.; Davey, Richard T.; Duprez, Daniel; Gatell, Jose M.; Hoy, Jennifer F.; Krum, Eric A.; Nelson, Ray; Pedersen, Court; Perez, George; Price, Richard W.; Prineas, Ronald J.; Rhame, Frank S.; Sampson, James H.; Worley, John; the INSIGHT Study Group // HIV Clinical Trials (Thomas Land Publishers Incorporated);Jul/Aug2010, Vol. 11 Issue 4, p205 

    Purpose: Serious non-AIDS (SNA) diseases are important causes of morbidity and mortality in the HAART era. We describe development of standard criteria for 12 SNA events for Endpoint Review Committee (ERC) use in START, a multicenter international HIV clinical trial. Methods: SNA definitions...

  • Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward. Cornu, Pieter; Steurbaut, Stephane; Šoštarić, Sabina; Mrhar, Aleš; Dupont, Alain // International Journal of Clinical Pharmacy;Jun2014, Vol. 36 Issue 3, p519 

    Background Drug-drug interactions (DDIs) can lead to adverse drug events and compromise patient safety. Two common approaches to reduce these interactions in hospital practice are the use of clinical decision support systems and interventions by clinical pharmacists. Objective To compare the...

  • Clinical outcomes following radial versus femoral artery access in primary or rescue percutaneous coronary intervention in Scotland: retrospective cohort study of 4534 patients. Johnman, Cathy; Pell, Jill P.; Mackay, Daniel F.; Behan, Miles; Slack, Rachel; Oldroyd, Keith G.; Berry, Colin // Heart;Apr2012, Vol. 98 Issue 7, p552 

    Objective To assess short-term and medium-term outcomes following radial and femoral artery access for primary or rescue percutaneous coronary intervention (PCI). Design Retrospective cohort study. Setting Scotland-wide. Patients All 4534 patients undergoing primary or rescue PCI in Scotland...

  • Estimating the Impact of the Discontinuation of Medical Interventions on Health Outcomes.  // American Journal of Epidemiology;Mar2009, Vol. 169 Issue 6, p653 

    The same study designs are used to document the magnitude of the influence of currently used and of previously used treatments on health outcomes. However, because randomized trials rarely are utilized to study cessation of treatment, most of what we know about the experience of former users of...

  • Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Greene, Stephen J.; Gheorghiade, Mihai; Vaduganathan, Muthiah; Ambrosy, Andrew P.; Mentz, Robert J.; Subacius, Haris; Maggioni, Aldo P.; Nodari, Savina; Konstam, Marvin A.; Butler, Javed; Filippatos, Gerasimos // European Journal of Heart Failure;Dec2013, Vol. 15 Issue 12, p1401 

    Aims Haemoconcentration has been studied as a marker of decongestion in patients with hospitalization for heart failure (HHF). We describe the relationship between haemoconcentration, worsening renal function, post-discharge outcomes, and clinical and laboratory markers of congestion in a large...

  • Growth-differentiation factor-15 and functional outcome after acute ischemic stroke. Gröschel, Klaus; Schnaudigel, Sonja; Edelmann, Frank; Niehaus, Cord-Friedrich; Weber-Krüger, Mark; Haase, Beatrice; Lahno, Rosine; Seegers, Joachim; Wasser, Katrin; Wohlfahrt, Janin; Vollmann, Dirk; Stahrenberg, Raoul; Wachter, Rolf // Journal of Neurology;Aug2012, Vol. 259 Issue 8, p1574 

    Blood biomarkers may improve the performance in predicting early stroke outcome beyond well-established clinical factors. We investigated the value of growth-differentiation factor-15 (GDF-15) to predict functional outcome after 90 days in a prospectively collected patient cohort with symptoms...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics